Microbot Price To Sales Ratio vs Dividend Yield Analysis

MBOT Stock

USD 2.11 0.11 5.50%

Microbot Medical financial indicator trend analysis is infinitely more than just investigating Microbot Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Microbot Medical is a good investment. Please check the relationship between Microbot Medical Price To Sales Ratio and its Dividend Yield accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Price To Sales Ratio vs Dividend Yield

Price To Sales Ratio vs Dividend Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Microbot Medical Price To Sales Ratio account and Dividend Yield. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Microbot Medical's Price To Sales Ratio and Dividend Yield is -0.27. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Dividend Yield in the same time period over historical financial statements of Microbot Medical, assuming nothing else is changed. The correlation between historical values of Microbot Medical's Price To Sales Ratio and Dividend Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Microbot Medical are associated (or correlated) with its Dividend Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Dividend Yield has no effect on the direction of Price To Sales Ratio i.e., Microbot Medical's Price To Sales Ratio and Dividend Yield go up and down completely randomly.

Correlation Coefficient

-0.27

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Microbot Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Microbot Medical sales, a figure that is much harder to manipulate than other Microbot Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Microbot Medical dividend as a percentage of Microbot Medical stock price. Microbot Medical dividend yield is a measure of Microbot Medical stock productivity, which can be interpreted as interest rate earned on an Microbot Medical investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Most indicators from Microbot Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Microbot Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.At this time, Microbot Medical's Issuance Of Capital Stock is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 22.4 M in 2026, whereas Selling General Administrative is likely to drop slightly above 4.3 M in 2026.

Microbot Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Property Plant And Equipment Gross	Short Term Investments	Common Stock	Common Stock Total Equity	Other Assets
Total Assets		0.58	0.51	0.59	0.67	0.71	-0.76	-0.61	0.12	0.91	0.76	0.58	0.97	0.03	-0.65	0.72	0.68	0.5	0.72	0.98	0.59	0.39	0.02	0.26	0.43	0.49
Short Long Term Debt Total	0.58		0.67	0.86	-0.09	0.94	-0.12	-0.76	0.27	0.62	0.69	0.14	0.49	0.08	-0.48	0.84	0.22	0.85	0.88	0.49	0.96	0.53	-0.52	-0.12	0.49	0.54
Other Current Liab	0.51	0.67		0.94	-0.15	0.74	-0.01	-0.85	0.35	0.35	0.71	0.58	0.36	0.12	-0.35	0.75	0.37	0.78	0.84	0.4	0.56	0.26	-0.43	0.16	0.63	0.22
Total Current Liabilities	0.59	0.86	0.94		-0.13	0.87	-0.06	-0.87	0.34	0.5	0.76	0.43	0.46	0.16	-0.4	0.85	0.34	0.86	0.92	0.48	0.8	0.4	-0.43	0.07	0.59	0.38
Total Stockholder Equity	0.67	-0.09	-0.15	-0.13		0.03	-0.93	0.14	-0.07	0.7	0.11	0.29	0.79	-0.07	-0.29	0.0	0.66	-0.18	-0.03	0.79	-0.04	0.07	0.36	0.13	-0.12	0.16
Property Plant And Equipment Net	0.71	0.94	0.74	0.87	0.03		-0.22	-0.85	0.33	0.67	0.84	0.38	0.58	0.05	-0.63	0.9	0.26	0.89	0.92	0.59	0.86	0.65	-0.46	-0.02	0.65	0.52
Net Debt	-0.76	-0.12	-0.01	-0.06	-0.93	-0.22		-0.01	-0.06	-0.86	-0.26	-0.38	-0.85	0.12	0.39	-0.16	-0.7	-0.04	-0.15	-0.84	-0.17	-0.19	-0.16	0.03	-0.06	-0.3
Retained Earnings	-0.61	-0.76	-0.85	-0.87	0.14	-0.85	-0.01		-0.11	-0.39	-0.91	-0.56	-0.44	-0.11	0.53	-0.95	-0.16	-0.84	-0.95	-0.45	-0.69	-0.38	0.3	-0.33	-0.77	-0.37
Accounts Payable	0.12	0.27	0.35	0.34	-0.07	0.33	-0.06	-0.11		0.19	0.13	0.13	0.06	0.05	-0.35	0.13	0.09	0.15	0.23	0.1	0.18	0.48	-0.16	-0.1	0.09	-0.02
Cash	0.91	0.62	0.35	0.5	0.7	0.67	-0.86	-0.39	0.19		0.57	0.38	0.93	-0.05	-0.56	0.57	0.67	0.48	0.58	0.93	0.63	0.43	-0.14	-0.09	0.3	0.51
Non Current Assets Total	0.76	0.69	0.71	0.76	0.11	0.84	-0.26	-0.91	0.13	0.57		0.68	0.61	0.08	-0.68	0.95	0.23	0.77	0.92	0.6	0.66	0.5	-0.13	0.29	0.78	0.58
Non Currrent Assets Other	0.58	0.14	0.58	0.43	0.29	0.38	-0.38	-0.56	0.13	0.38	0.68		0.46	-0.14	-0.58	0.51	0.44	0.42	0.51	0.49	0.09	0.24	0.03	0.3	0.77	0.04
Cash And Short Term Investments	0.97	0.49	0.36	0.46	0.79	0.58	-0.85	-0.44	0.06	0.93	0.61	0.46		0.02	-0.55	0.58	0.71	0.36	0.57	0.99	0.52	0.32	0.11	0.22	0.25	0.45
Net Receivables	0.03	0.08	0.12	0.16	-0.07	0.05	0.12	-0.11	0.05	-0.05	0.08	-0.14	0.02		0.16	0.09	-0.16	0.11	0.11	0.01	0.16	0.0	0.15	0.01	-0.13	0.22
Common Stock Shares Outstanding	-0.65	-0.48	-0.35	-0.4	-0.29	-0.63	0.39	0.53	-0.35	-0.56	-0.68	-0.58	-0.55	0.16		-0.64	-0.38	-0.39	-0.61	-0.58	-0.45	-0.54	0.04	-0.25	-0.62	-0.25
Non Current Liabilities Total	0.72	0.84	0.75	0.85	0.0	0.9	-0.16	-0.95	0.13	0.57	0.95	0.51	0.58	0.09	-0.64		0.24	0.81	0.98	0.58	0.81	0.46	-0.24	0.3	0.71	0.57
Other Current Assets	0.68	0.22	0.37	0.34	0.66	0.26	-0.7	-0.16	0.09	0.67	0.23	0.44	0.71	-0.16	-0.38	0.24		0.1	0.3	0.76	0.22	0.04	0.0	0.14	0.07	0.12
Other Stockholder Equity	0.5	0.85	0.78	0.86	-0.18	0.89	-0.04	-0.84	0.15	0.48	0.77	0.42	0.36	0.11	-0.39	0.81	0.1		0.85	0.37	0.76	0.43	-0.62	-0.23	0.76	0.43
Total Liab	0.72	0.88	0.84	0.92	-0.03	0.92	-0.15	-0.95	0.23	0.58	0.92	0.51	0.57	0.11	-0.61	0.98	0.3	0.85		0.58	0.84	0.46	-0.31	0.23	0.69	0.52
Total Current Assets	0.98	0.49	0.4	0.48	0.79	0.59	-0.84	-0.45	0.1	0.93	0.6	0.49	0.99	0.01	-0.58	0.58	0.76	0.37	0.58		0.51	0.32	0.06	0.22	0.27	0.42
Short Term Debt	0.59	0.96	0.56	0.8	-0.04	0.86	-0.17	-0.69	0.18	0.63	0.66	0.09	0.52	0.16	-0.45	0.81	0.22	0.76	0.84	0.51		0.5	-0.33	-0.09	0.39	0.56
Property Plant And Equipment Gross	0.39	0.53	0.26	0.4	0.07	0.65	-0.19	-0.38	0.48	0.43	0.5	0.24	0.32	0.0	-0.54	0.46	0.04	0.43	0.46	0.32	0.5		-0.04	-0.07	0.34	0.28
Short Term Investments	0.02	-0.52	-0.43	-0.43	0.36	-0.46	-0.16	0.3	-0.16	-0.14	-0.13	0.03	0.11	0.15	0.04	-0.24	0.0	-0.62	-0.31	0.06	-0.33	-0.04		0.56	-0.41	-0.13
Common Stock	0.26	-0.12	0.16	0.07	0.13	-0.02	0.03	-0.33	-0.1	-0.09	0.29	0.3	0.22	0.01	-0.25	0.3	0.14	-0.23	0.23	0.22	-0.09	-0.07	0.56		0.05	-0.06
Common Stock Total Equity	0.43	0.49	0.63	0.59	-0.12	0.65	-0.06	-0.77	0.09	0.3	0.78	0.77	0.25	-0.13	-0.62	0.71	0.07	0.76	0.69	0.27	0.39	0.34	-0.41	0.05		0.15
Other Assets	0.49	0.54	0.22	0.38	0.16	0.52	-0.3	-0.37	-0.02	0.51	0.58	0.04	0.45	0.22	-0.25	0.57	0.12	0.43	0.52	0.42	0.56	0.28	-0.13	-0.06	0.15

Click cells to compare fundamentals

Microbot Medical Account Relationship Matchups

Microbot Medical fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	16.8M	9.5M	8.3M	6.0M	5.4M	5.2M
Short Long Term Debt Total	680K	462K	231K	111K	99.9K	94.9K
Other Current Liab	1.4M	1.7M	3.2M	2.2M	2.6M	3.3M
Total Current Liabilities	2.0M	2.1M	3.8M	2.5M	2.8M	4.7M
Total Stockholder Equity	14.4M	7.3M	4.5M	3.5M	3.2M	3.0M
Property Plant And Equipment Net	888K	723K	406K	212K	190.8K	181.3K
Net Debt	(12.8M)	(2.1M)	(2.2M)	(3.0M)	(2.7M)	(2.8M)
Retained Earnings	(55.6M)	(68.8M)	(79.5M)	(90.9M)	(81.8M)	(85.9M)
Accounts Payable	279K	116K	357K	165K	148.5K	141.1K
Cash	13.5M	2.5M	2.5M	3.1M	2.8M	2.7M
Non Current Assets Total	888K	723K	406K	212K	190.8K	181.3K
Cash And Short Term Investments	15.5M	8.3M	6.4M	5.5M	6.3M	6.0M
Net Receivables	174K	103K	1.5M	300K	345K	348.8K
Common Stock Shares Outstanding	7.1M	7.3M	10.2M	15.6M	18.0M	18.9M
Liabilities And Stockholders Equity	16.8M	9.5M	8.3M	6.0M	5.4M	5.2M
Non Current Liabilities Total	402K	179K	40K	41K	36.9K	35.1K
Other Current Assets	605K	213K	432K	49K	44.1K	41.9K
Other Stockholder Equity	69.9M	76.0M	83.9M	94.3M	108.4M	113.8M
Total Liab	2.4M	2.2M	3.8M	2.5M	2.3M	2.1M
Total Current Assets	15.9M	8.8M	7.9M	5.8M	5.2M	5.0M
Short Term Debt	278K	283K	191K	70K	63K	59.9K
Property Plant And Equipment Gross	1.2M	1.1M	899K	796K	716.4K	680.6K
Short Term Investments	2.0M	5.8M	3.9M	2.4M	2.1M	3.6M
Inventory	(5K)	(174K)	(103K)	(42K)	(37.8K)	(39.7K)
Net Tangible Assets	31.5M	24.3M	14.4M	7.3M	8.4M	11.1M
Property Plant Equipment	228K	1.0M	888K	723K	650.7K	1.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC